Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome

Diabetes-associated chronic kidney disease is a pandemic issue. Despite the global increase in the number of individuals with this chronic condition together with increasing morbidity and mortality, there are currently only limited therapeutic options to slow disease progression. One of the reasons...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Ashani Lecamwasam, Elif I. Ekinci, Richard Saffery, Karen M. Dwyer
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Subjects:	diabetes chronic kidney disease biomarker epigenetics metabolomics gut microbiome
Online Access:	https://www.mdpi.com/2227-9059/8/9/341